A scalable CAR-T cell manufacturing workflow producing 100+ doses per batch
Pierre Springuel, PhD, Rukmini Ladi
Improved gene delivery and T Cell editing using cell free DNA and novel non viral delivery solutions
Claire Gueguen, PhD, Peter Archibald, PhD
Cell-derived nanoparticles: a new paradigm for CAR-T cell activation and manufacturing
P Moura, B Shy, K Li et al.
Accelerating success: advanced developability strategies for bioconjugates and ADCs
Yvette Stallwood, PhD, Raphael Frey, PhD